Physician-Scientist and Executive Leader, Licensed, Board Certified Physician , over 15 years of drug development experience on the industry side, all phases of clinical trials, regulatory filings, multiple therapeutic areas, development strategy, due diligence and medical affairs. Executive management experience, building and leading clinical development organizations, fund raising and managing a portfolio. Experienced Team leader for multifunctional matrix teams. Early Clinical Development - translational support for early products, clinical leadership, medical monitoring, therapeutic area strategy and CDP development, business development and due diligence, IND/CTA filing, building and sustaining external resource networks and partnerships. Worked on multiple areas including Rare diseases, Diabetes, Obesity, Osteoporosis, NASH, Hyperlipidemia, Wound Healing, Immunology and Inflammation, ITP, Hemophilia and Sickle cell disease, Dermatology, CKD, Pulmonology and Ophthalmology.Late stage work - Led Phase 2 and 3, multinational trials. Experience with pharmacovigilance, safety monitoring, regulatory reporting and medical communication. Support for development execution and communication of the global scientific medical evidence plan, cross-functional and global collaborations to integrate broad medical scientific and commercial input into the development program, supporting the development of key scientific external relationships with opinion leaders. Exposure to preparation for NDA filing.Medical affairs work including RML training, Investigator Sponsored Studies and assessment and approval of scientific materials. Clinical practice, teaching and research at Health Partners and Regions Hospital in Minneapolis-St. Paul, the University of Minnesota and the Health Partners Institute for Education and Research. Advanced diabetes research at the Mayo Clinic. Strong presentation and leadership skills. Scientific presentations at national and international meetings and to regulatory authorities. Governance and leadership experience with medical specialty groups and a large non-profit advocacy group including invited testimonies to US Senate and House committees and presentations at the White House.